The PennZone

  • Home
  • Business
  • Non-profit
  • Health
  • Technology
  • Construction
  • Travel
  • Real Estate
  • Entertainment

Lineus Medical Receives Innovative Technology Contract from Vizient for SafeBreak® Vascular
The PennZone/10180170

Trending...
  • "They Said It Was Impossible": This Bottle Turns Any Freshwater Source Into Ice-Cold, Purified Drinking Water in Seconds
  • TL International Group Becomes First Global Operator to Fully Migrate to Pulsant's Dedicated Car Rental Cloud
  • Excel Signworks Introduces Custom Lobby Signs to Help Pittsburgh Businesses Elevate First Impressions in 2026
Lineus Medical
Contract awarded for products that bring improvement to health care industry

FAYETTEVILLE, Ark. - PennZone -- Lineus Medical announced its SafeBreak® Vascular has received an Innovative Technology contract from Vizient, Inc. the nation's largest member-driven health care performance improvement company. The contract was awarded based on the recommendation of SafeBreak Vascular by hospital experts who serve on one of Vizient's member-led councils, and it signifies to Vizient members unique qualities that potentially bring improvement to the health care industry.

Innovative Technology contracts are recommended after review and interaction with products submitted through Vizient's Innovative Technology Program. Vizient member-led councils identify technologies that have the potential to enhance clinical care, patient safety, health care worker safety or improve business operations of health care organizations.

SafeBreak Vascular is the first of its kind Force-Activated Separation Device (FASD) on the market. SafeBreak is installed in the patient's IV line and separates when a harmful force is placed on an IV line, protecting the IV catheter. When it separates, valves on each side close to prevent the loss of blood and medication. In a large randomized controlled trial, SafeBreak reduced IV complications requiring an IV restart by 44%1. SafeBreak is the first FASD on the market to utilize this innovative approach of intentionally being the weak link in the IV line, giving clinicians the ability to address a long felt problem with a novel solution.

More on The PennZone
  • PRÝNCESS Builds Anticipation With "My Nerves" — A Girls-Girl Anthem
  • Arbutus Medical Raises C$9.3M to Accelerate Growth of Surgical Workflow Solutions Outside the OR
  • From Sleepless Nights to Sold-Out Drops: Catch Phrase Poet's First Year Redefining Motivational Urban Apparel
  • Now Live on Kickstarter: The Bottle That Chills and Purifies Any Freshwater — and Donates One for Every 10 Backers
  • How Specialized Game Development Services Are Powering the Next Wave of Interactive Entertainment

"We're thrilled to receive this Innovative Technology contract offering Vizient members easier access to SafeBreak Vascular and view this as further validation of the way it addresses the persistent problem of IV complications," said Vance Clement, CEO of Lineus Medical. "We believe integrating SafeBreak into clinical practice is a critical step towards Force-Activated Separation Devices becoming the standard of care for IV therapy," said Spencer Jones, Founder and Chief Technology Officer of Lineus Medical.

"Our member councils reviewed and determined SafeBreak Vascular should be recognized with an Innovative Technology contract based on its potential to make an incremental difference in health care," said Kelly Flaharty, director of contract process for Vizient. "Congratulations to Lineus Medical on receiving this contract status."

Vizient represents a diverse membership base that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents more than $100 billion in annual purchasing volume. Through its Innovative Technology Program, Vizient works with member-led councils and task forces to evaluate products for their potential to bring real innovation to health care. Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle.

More on The PennZone
  • Brain Drain Unlimited Strengthens Legal Advocacy with Advanced Training from Villanova University
  • Don't Settle for a Lawyer Who Just Speaks Spanish. Demand One Who Understands Your Story
  • Dan Williams Promoted to Century Fasteners Corp. – General Manager, Operations
  • Ski Johnson Inks Strategic Deals with Three Major Food Chain Brands
  • NIL Club Advances Agent-Free NIL Model as Oversight Intensifies Across College Athletics

###

Lineus Medical is the developer of a patented, break-away technology designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and other medical tubing may be reduced when a force-activated separation device is used. Learn more
at www.lineusmed.com and follow us on LinkedIn or Twitter.

1. Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2016; 38(3): 189-203.

MKG-0135 Rev. 00

Source: Lineus Medical

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Patron Saints Of Music Names Allie Moskovits Head Of Sync & Business Development
  • Dave Aronberg Named 2026 John C. Randolph Award Recipient by Palm Beach Fellowship of Christians & Jews
  • General Relativity Challenged by New Tension Discovered in Dark Siren Cosmology
  • Burkentine Real Estate Group to Bring A New Community to Millersville, Pennsylvania
  • Unseasonable Warmth Triggers Early Pest Season Along I-5 Corridor
  • VIP Vacations Named Winner in 2026 WeddingWire Couples' Choice Awards®
  • Colonial Nissan Champions Community Service and Trust Across the Greater Philadelphia Region
  • Bug Busters Expands Service Footprint With New Carrollton, Georgia Branch
  • Why KULR Could Be a Quiet Enabler of Space-Based Solar Power (SBSP) Over The Long Term: KULR Technology Group, Inc. (NY SE American: KULR)
  • Why Finland Had No Choice But to Legalize Online Gambling
  • High-Margin Energy & Digital Infrastructure Platform Created after Merger with Established BlockFuel Energy, Innovation Beverage Group (NAS DAQ: IBG)
  • iFLO Pro Launches Its Groundbreaking iFLO Pro Mini At The 2026 AHR Expo In Las Vegas
  • TL International Group Becomes First Global Operator to Fully Migrate to Pulsant's Dedicated Car Rental Cloud
  • Diveroli Investment Group Files 13D in PetMed Express, Highlights Strategic Value, Asset Floor, and Multiple Takeover Pathways
  • Excel Signworks Introduces Custom Lobby Signs to Help Pittsburgh Businesses Elevate First Impressions in 2026
  • Deep Learning Robotics (DLRob) Announces Pre-Launch of Zero-Teach and Teach-by-Demonstration Technology for Kitting Applications
  • The Quasar Dipole Phenomenon is likely just a complex systematics artifact
  • The Rise of Comprehensive Home Water Treatment Systems
  • Yazaki Innovations to Introduce First-Ever Prefabricated Home Wiring System to U.S. Residential Market in 2026
  • Bisnar Chase Named 2026 Law Firm of the Year by Best Lawyers

Popular on PennZone

  • Mark Schork Selected As 'Board Observer' By Philadelphia Bar Foundation - 168
  • Michael Judkins Releases New Poetry Book, Deeper Than You Think
  • Steve Everett Jr. Named President of L.T. Hampel Corporation
  • $80 Million Revenue Backlog for AI Cybersecurity Company Building the Future of Integrated Cybersecurity and Public Safety: $CYCU
  • Precision Adult Care Expands 24/7 Adult In-Home Care Services to Meet Growing Demand in the Coachella Valley
  • Accountants Near Me Cheyenne Opens U.S. Directory for Accountants, Bookkeepers and Tax Services
  • Boston Industrial Solutions' BPA Certified BX Series Raises the Bar for Pad Printing Inks
  • Why 'Instant-Liquidity' Gaming is Dominating the Nordic Tech Demographic
  • NOW OPEN - New Single Family Home Community in Manalapan
  • Boston Industrial Solutions' Natron® 512N Series UV LED Ink Earns CPSIA Certification

Similar on PennZone

  • FDA Meeting Indicates a pivotal development that could redefine the treatment landscape for suicidal depression via NRx Pharmaceuticals: $NRXP
  • CCHR: Decades of Warnings, Persistent Inaction; Studies Raise New Alarms on Psychiatric Drug Safety
  • Arbutus Medical Raises C$9.3M to Accelerate Growth of Surgical Workflow Solutions Outside the OR
  • Now Live on Kickstarter: The Bottle That Chills and Purifies Any Freshwater — and Donates One for Every 10 Backers
  • Families Gain Clarity: Postmortem Pathology Expands Private Autopsy Services in St. Louis
  • Amy Turner Receives 2025 ENPY Partnership Builder Award from The Community Foundation
  • "They Said It Was Impossible": This Bottle Turns Any Freshwater Source Into Ice-Cold, Purified Drinking Water in Seconds
  • Aleen Inc. (C S E: ALEN.U) Advances Digital Wellness Vision with Streamlined Platform Navigation and Long-Term Growth Strategy
  • 20/20 Institute Launches Updated Vision Correction Procedures Page for Denver & Colorado Springs
  • NRE-HEALTH Radio Launches With a New Approach to Health Broadcasting
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us